"It's not like I can change my mind later": Reversibility and decision timing in prostate cancer treatment decision-making

Patient Education and Counseling

Volumn 77, Issue 2, 2009, Pages 302-307

  Henrikson, Nora B ^a   Ellis, William J ^b   Berry, Donna L ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c University of Washington School of Nursing Biobehavioral Nursing and Health Systems   (United States)

Author keywords

Decision making; Prostate cancer; Qualitative research; Reversibility

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER SURGERY; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL DECISION MAKING; HUMAN; MALE; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; QUALITATIVE ANALYSIS; UNSTRUCTURED INTERVIEW;

AGED; DECISION MAKING; FEMALE; FOCUS GROUPS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; PROSTATIC NEOPLASMS; TIME FACTORS; UNCERTAINTY;

EID: 70350084954     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2009.03.017     Document Type: Article

References (29)

1. ACS. Cancer facts and figures 2008 (2008), American Cancer Society, Atlanta
2. Gwede C.K., Pow-Sang J., Seigne J., Heysek R., Helal M., Shade K., Cantor A., and Jacobsen P.B. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer 104 (2005) 1381-1390
3. Steginga S.K., Occhipinti S., Gardiner R.A., Yaxley J., and Heathcote P. Making decisions about treatment for localized prostate cancer. BJU Int 89 (2002) 255-260
4. Berry D.L., Ellis W.J., Woods N.F., Schwien C., Mullen K.H., and Yang C. Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol 21 (2003) 93-100
5. Hu J.C., Kwan L., Saigal C.S., and Litwin M.S. Regret in men treated for localized prostate cancer. J Urol 169 (2003) 2279-2283
6. Henry C. Investment decisions under uncertainty: the "irreversibility effect". Am Econ Rev 64 (1974) 1006-1012
7. Palmer S., and Smith P.C. Incorporating option values into the economic evaluation of health care technologies. J Health Econ 19 (2000) 755-766
8. Anderson C.J. The psychology of doing nothing: forms of decision avoidance result from reason and emotion. Psychol Bull 129 (2003) 139-167
9. Neuendorf K.A. The content analysis guidebook (2002), Sage Publications, Thousand Oaks, CA
10. Strauss A.L., and Corbin J.M. Basics of qualitative research: techniques and procedures for developing grounded theory. 2nd ed. (1998), Sage Publications, Thousand Oaks
11. Creswell J. Qualitative inquiry and research design. 2nd ed. (2007), Sage Publications, Thousand Oaks, CA
12. Chapman G.B. Short-term cost for long-term benefit: time preference and cancer control. Health Psychol 24 (2005) S41-S48
13. Arrow K., and Fisher A. Environmental preservation, uncertainty, and irreversibility. Quart J Econ 88 (1974) 312-319
14. Kovats R.S., Campbell-Lendrum D., and Matthies F. Climate change and human health: estimating avoidable deaths and disease. Risk Anal 25 (2005) 1409-1418
15. Lasserre P., Moatti J.P., and Soubeyran A. Early initiation of highly active antiretroviral therapies for AIDS: dynamic choice with endogenous and exogenous learning. J Health Econ 25 (2006) 579-598
16. Driffield T., and Smith P.C. A real options approach to watchful waiting: theory and an illustration. Med Decis Making 27 (2007) 178-188
17. Callan V.J. Voluntary childlessness: early articulator and postponing couples. J Biosoc Sci 16 (1984) 501-509
18. Baum F. Voluntary childlessness and contraception: problems and practices. J Biosoc Sci 14 (1982) 17-23
19. Hall J.D., Boyd J.C., Lippert M.C., and Theodorescu D. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology 61 (2003) 402-407
20. Mazur D.J., and Merz J.F. Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancer. J Am Geriatr Soc 43 (1995) 979-984
21. Denberg T.D., Melhado T.V., and Steiner J.F. Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer 107 (2006) 620-630
22. Berry D.L., Ellis W.J., Russell K.J., Blasko J.C., Bush N., Blumenstein B., and Lange P.H. Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer. Clin Genitourin Cancer 5 (2006) 219-226
23. Mazur D.J., and Hickam D.H. Patient preferences for management of localized prostate cancer. West J Med 165 (1996) 26-30
24. Feldman-Stewart D., Brundage M.D., Hayter C., Groome P., Curtis Nickel J., Downes H., and Mackillop W.J. What questions do patients with curable prostate cancer want answered?. Med Decis Making 20 (2000) 7-19
25. Feldman-Stewart D., Brundage M.D., Nickel J.C., and Mackillop W.J. The information required by patients with early-stage prostate cancer in choosing their treatment. BJU Int 87 (2001) 218-223
26. Feldman-Stewart D., Brundage M.D., Van Manen L., and Svenson O. Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid. Health Expect 7 (2004) 126-141
27. Dahm P., Yeung L.L., Chang S.S., and Cookson M.S. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. J Urol 180 (2008) 451-460
28. Couzens G. Detection comes earlier, and so do tough questions (2007), New York Times, New York, NY
29. Feldman-Stewart D., Brennenstuhl S., and Brundage M. The information needed by Canadian early-stage prostate cancer patients for decision-making: stable over a decade. Patient Educ Couns 73 (2008) 437-442